Stomach Cancer
122
23
27
53
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
16 trials with published results (13%)
Research Maturity
53 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.2%
10 terminated out of 122 trials
84.1%
-2.4% vs benchmark
7%
9 trials in Phase 3/4
30%
16 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 53 completed trials
Clinical Trials (122)
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Brodalumab in the Treatment of Immune-Related Adverse Events
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Large Language Models Assist in Tumor MDT
Cancer Loyalty Card Study 2 (CLOCS-2)
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
The PLATON Network
Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Evaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer Screening
Target-specific immunoPET Imaging of Digestive System Carcinoma